XML 50 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Schedule of Total Stock-Based Compensation Expense Included in Company's Consolidated Statements of Income and Comprehensive Income

The total stock-based compensation expense included in the Company’s consolidated statements of income and comprehensive income was as follows:

 

     Three Months Ended March 31,  
     2019      2018  

Cost of revenues

   $ 422      $ 1,005  

Research and development expense

     810        722  

Selling, general and administrative expense

     8,038        8,699  

Acquisition and integration related expense

     18,568        —    
  

 

 

    

 

 

 

Total pre-tax stock-based compensation expense

   $ 27,838      $ 10,426  
  

 

 

    

 

 

 
Summary of Activity for RSUs

The following table presents the activity for RSUs under the Plan:

 

     Three Months Ended March 31, 2019  
     Outstanding RSUs      Weighted Average
Grant Date
Fair Value
 

RSUs – beginning of period

     647,394      $ 74.04  

Assumed shares from ESI Merger

     736,133      $ 84.10  

Accrued dividend shares

     1,558      $ 78.45  

Granted

     182,212      $ 82.58  

Vested

     (274,898    $ 67.57  

Forfeited

     (76,096    $ 91.14  
  

 

 

    

RSUs – end of period

     1,216,303      $ 81.81  
  

 

 

    
Stock Appreciation Rights (SARs) [Member]  
Summary of Activity for Outstanding and Exercisable Stock Appreciation Rights

The following table presents the activity for SARs under the Plan:

 

     Three Months Ended March 31, 2019  
     Outstanding SARs      Weighted Average
Grant Date
Fair Value
 

SARs – beginning of period

     177,538      $ 28.52  

Assumed SARs from ESI Merger

     12,787      $ 17.38  

Exercised

     (23,569    $ 27.34  

Forfeited or expired

     (184    $ 27.89  
  

 

 

    

SARs Outstanding – end of period

     166,572      $ 27.86